Thrombocytopenia Associated With Use of a Biocompatible Hemodialysis Membrane: A Case Report

American Journal of Kidney Diseases

Volumn 55, Issue 6, 2010, Pages

  Post, James B ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Hemodialysis; thrombocytopenia; thrombosis

Indexed keywords

D DIMER;

AGED; ARTERIOVENOUS SHUNT; ARTERY THROMBOSIS; ARTICLE; ARTIFICIAL KIDNEY; BIOCOMPATIBILITY; BLEEDING; CASE REPORT; CHRONIC KIDNEY DISEASE; DIALYSIS MEMBRANE; HUMAN; HUMAN CELL; MALE; SKIN BRUISING; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT DURATION; VEIN THROMBOSIS;

AGED, 80 AND OVER; BIOCOMPATIBLE MATERIALS; CHRONIC DISEASE; HUMANS; KIDNEY DISEASES; MALE; MEMBRANES, ARTIFICIAL; POLYMERS; RENAL DIALYSIS; SULFONES; THROMBOCYTOPENIA;

EID: 77952554373     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.10.059     Document Type: Article

References (15)

1. Craddock P.R., Fehr J., Dalmasso A.P., Brighan K.L., and Jacob H.S. Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J Clin Invest 59 (1977) 879-888
2. Hakim R.M., and Schafer A.I. Hemodialysis-associated platelet activation and thrombocytopenia. Am J Med 78 (1985) 575-580
3. Chenoweth D.E. Complement activation in extracorporeal circuits. Ann N Y Acad Sci 516 (1987) 306-313
4. Chenoweth D.E., and Henderson L.W. Complement activation during hemodialysis: laboratory evaluation of hemodialyzers. Artif Organs 11 (1987) 155-162
5. Tabor B., Geissler B., Odell R., Schmidt B., Blumenstein M., and Schindhelm K. Dialysis neutropenia: the role of the cytoskeleton. Kidney Int 53 (1998) 783-789
6. Lotner G.Z., Lynch J.M., Betz S.J., and Henson P.M. Human neutrophil-derived platelet activating factor. J Immunol 124 (1980) 676-684
7. Stimler N.P., Bloor C.M., Hugli T.E., Wykle R.L., McCall C.E., and O'Flaherty J.T. Anaphylactic actions of platelet-activating factor. Am J Pathol 105 (1981) 64-69
8. Muhlfelder T.W., Niemetz J., Kreutzer D., Beebe D., Ward P.A., and Rosenfeld S.I. C5 chemotactic fragment induces leukocyte production of tissue factor activity: a link between complement and coagulation. J Clin Invest 63 (1979) 147-150
9. Polley M.J., and Nachman R.L. Human platelet activation by C3a and C3a des-arg. J Exp Med 158 (1983) 603-615
10. Frank R.D., Weber J., Dresbach H., Thelen H., Weiss C., and Floege J. Role of contact system activation in hemodialyzer-induced thrombogenicity. Kidney Int 60 (2001) 1972-1981
11. Cotran R.S., Kumar V., and Collins T. Robbins Pathologic Basis of Disease (1999), W.B. Saunders Co, Philadelphia, PA
12. Hoenich N.A., Woffindin C., Brennan A., Cox P.J., Matthews J.N., and Goldfinch M. A comparison of three brands of polysulfone membranes. J Am Soc Nephrol 7 (1996) 871-876
13. Honda H., Tsukamoto I., Murasugi H., et al. Effect of polysulfone membrane dialyzers on the coagulation system. Jpn J High Performance Membr 59 (2005) 77-81
14. Taguchi N., Tsukamoto I., Yamashita Y., et al. Effects of differences in dialyzers and anticoagulant dosage on blood activation. Jpn J High Performance Membr 61 (2006) 206-209
15. Brendolan A., Nalesso F., Fortunato A., et al. Dialytic performance evaluation of Rexeed: a new polysulfone-based dialyzer with improved flow distributions. Int J Artif Organs 28 (2005) 966-975